Last quarter (Q4 2023), Pharmagreen Biotech's total revenue was $1.24K, an increase of Infinity% from the same quarter last year. In Q4, Pharmagreen Biotech's net income was $-144.85K. See Pharmagreen Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Total Revenue	$ 2.80K	$ 3.00K	-	-	$ 0.00	$ 0.00
Cost of Revenue	$ 1.85K	$ 2.07K	-	-	-	-
Gross Profit	$ 943.00	$ 930.00	-	-	-	-
Operating Expense	$ 287.49K	$ 474.94K	$ 1.07M	$ 752.73K	$ 485.75K	$ 648.32K
Operating Income	$ -286.55K	$ -474.01K	$ -1.07M	$ -752.73K	$ -485.75K	$ -648.32K
Net Non Operating Interest Income Expense	$ -24.84K	$ -55.87K	$ -28.78K	$ 768.98K	$ -672.27K	$ -126.63K
Other Income Expense	$ 188.06K	$ 42.90K	$ -254.77K	$ -3.01M	$ -1.32M	$ 6.14K
Pretax Income	$ -495.77K	$ -568.80K	$ -875.50K	$ -4.53M	$ -2.48M	$ -768.81K
Tax Provision	-	-	-	-	-	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -495.74K	$ -568.77K	$ -875.48K	$ -4.53M	$ -2.44M	$ -767.54K
Basic EPS	-	-	-	$ -0.02	$ -0.03	$ -0.01
Diluted EPS	-	-	-	$ -0.02	$ -0.03	$ -0.01
Basic Average Shares	$ 1.55B	$ 466.53M	$ 403.73M	$ 293.71M	$ 82.07M	$ 74.06M
Diluted Average Shares	$ 1.55B	$ 466.53M	$ 403.73M	$ 293.71M	$ 82.07M	$ 74.06M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 289.35K	$ 477.01K	$ 1.07M	$ -752.73K	$ 485.75K	$ 648.32K
Net Income From Continuing And Discontinued Operation	$ -495.74K	$ -568.77K	$ -875.48K	$ -4.53M	$ -2.44M	$ -767.54K
Normalized Income	$ -401.32K	$ -418.07K	$ -643.50K	$ -3.57M	$ -853.81K	$ -773.68K
Interest Expense	-	-	-	-	$ 672.27K	$ 5.08K
EBIT	$ -470.92K	$ -512.93K	$ -846.73K	$ -3.76M	$ -1.81M	$ -763.73K
EBITDA	$ -470.92K	$ -512.93K	$ -846.73K	$ -3.76M	$ -1.81M	$ -763.73K

Currency in USD

Pharmagreen Biotech Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing